Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways

Yi-Jin Chen(Kaohsiung Medical University), Wan-Chi Tsai(Kaohsiung Medical University)
PLoS ONE
August 22, 2017
Cited by 35


Related Papers